Capim is a "buy now, pay later” fintech company starting by offering credit to low-income patients in need of minor surgeries and other high-ticket medical procedures. On top of that, as the company generates additional demand for the clinics, reducing the idle capacity, it is also able to charge a take-rate from clinics.
In Brazil, more than 160 million people are without a private health plan, and many of them do not have credit cards or other forms of credit that could be used at the point of sale. The ophthalmology sector alone represents a US$2 billion industry annually distributed among 5,000 clinics. Capim will start with this sector before expanding to other categories in the US$39 billion out-of-pocket market. In its first months of operations, Capim is financing simple cataract surgeries in a clinic. This type of procedure can change a patient’s quality of life, but without Capim many patients wouldn’t be able to afford it or would rely on a long waiting list from the local and public health system (namely SUS).
When we look at the POS lending ecosystem as a whole, we see a revolution in credit happening globally across many sectors such as car dealerships, agro machinery stores, and real estate. The value proposition for all of them is the same: By giving away a take-rate, the store (or clinic) can increase sales. The advantage for a health clinic of following this model is that many procedures have high margins. For example, for very expensive exams, some clinics have an underused and expensive machine, and an additional exam brings a relevant marginal revenue.
Capim was co-founded by MBAs from INSEAD. Before INSEAD, Roberto Biselli was head of CX at Basement and a consultant at McKinsey. Marcelo Lutz was a private equity investor at HIG and Graycliff Partners.
Capim is a "buy now, pay later” fintech company starting by offering credit to low-income patients in need of minor surgeries and other high-ticket medical procedures. On top of that, as the company generates additional demand for the clinics, reducing the idle capacity, it is also able to charge a take-rate from clinics.
In Brazil, more than 160 million people are without a private health plan, and many of them do not have credit cards or other forms of credit that could be used at the point of sale. The ophthalmology sector alone represents a US$2 billion industry annually distributed among 5,000 clinics. Capim will start with this sector before expanding to other categories in the US$39 billion out-of-pocket market. In its first months of operations, Capim is financing simple cataract surgeries in a clinic. This type of procedure can change a patient’s quality of life, but without Capim many patients wouldn’t be able to afford it or would rely on a long waiting list from the local and public health system (namely SUS).
When we look at the POS lending ecosystem as a whole, we see a revolution in credit happening globally across many sectors such as car dealerships, agro machinery stores, and real estate. The value proposition for all of them is the same: By giving away a take-rate, the store (or clinic) can increase sales. The advantage for a health clinic of following this model is that many procedures have high margins. For example, for very expensive exams, some clinics have an underused and expensive machine, and an additional exam brings a relevant marginal revenue.
Capim was co-founded by MBAs from INSEAD. Before INSEAD, Roberto Biselli was head of CX at Basement and a consultant at McKinsey. Marcelo Lutz was a private equity investor at HIG and Graycliff Partners.